Selvaraj, Periasamy
- Emory University · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #19,197
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2003 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$625.5K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#19,197
By linked amount among FY2023 PIs
Earliest Year Loaded
2003
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Selvaraj, Periasamy as a PI. Multi-PI records show the full award amount for context.
- 1R01CA262123-01A1R01Contact PIPersonalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neckEmory University · Internal Medicine (NIH department code)$625.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Selvaraj, Periasamy as a PI.
FY2023 award administered by Emory University (GA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2003First NIH AwardEmory University
- 2004$500K Cumulative Funding
- 2004R01 Grant Holder
- 2023$1M Cumulative Funding